🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Looking forward to seeing all of you at BIOS and sharing our fully in vitro human lymph node technology platform EXIS.

The Externalized Immune System (EXIS™) platform eliminates the use of animals and shortens the #AntibodyDiscovery process from 12 months to just 16 days with our lymph node organoid (LNO™) technology. prellisbio.com #Biotech #JPM2022 #JPM22

CEO Melanie Matheu, PhD, PhD presents Prellis' in vitro #antibody drug discovery and early drug development platform on our PartneringONE profile at Biotech Showcase 2022. Find us for a virtual meeting via BIO One-on-One Partnering or PartneringONE. #Biotech #JPM2022 #JPM22

Prellis Biologics Announces Collaboration and License Agreement with Bristol Myers Squibb Bristol Myers Squibb using the EXIS platform for high affinity human antibody discovery. businesswire.com/news/home/2022…

Prellis’ #3D #tumor models allow for testing #therapeutic candidates in discovery, development, and preclinical studies and can support a #CoCulture of #tumor cells and #immune cells. prellisbio.com #Biotech

EXIS (Externalized Immune System) is the first fully human immune system platform that enables high affinity human antibody discovery and screening of therapeutics in a fully human immune system. #3Dprinting #drugdiscovery #clinicaltrials

Proud of our CEO Dr. Melanie Matheu Melanie Matheu, PhD Thank you Scispot (YC S21) for recognizing #scientific innovation driven by #femalefounders creating powerful companies.

Next week, Prellis is hosting Dr. David Schaffer, Professor at UC Berkeley, at our TEJC #webinar. Join us for his presentation, "Molecular Elucidation and #Engineering of #StemCell Fate Decisions." Register at bit.ly/3uEJTy0. #Biotech #TissueEngineering

Join us this Friday at 12pm PT for Dr. David Schaffer's #TissueEngineering Journal Club #webinar presentation, "Molecular Elucidation and #Engineering of #StemCell Fate Decisions." Register at bit.ly/3uEJTy0. #Biotech #STEM #Seminar QB3-Berkeley UC Berkeley

Another day in the lab doing #AntibodyDiscovery and #immunogenicity testing with the Prellis bio team. Prellisbio.com #Biotech #STEM #Antibody #Antibodies #ImmuneSystem

Had a fantastic time with the Cantos team discussing our human #antibody platform derived from first in class lymph node organoids — and how application of our holographic laser printing has opened the door to a multitude of human tissue applications/products.

We are looking forward to #BioEurope Spring 2022! Connect with us for a virtual meeting via the PartneringONE platform to learn more about our Externalized Immune System (EXIS™) platform for #AntibodyDiscovery and #Immunogenicity testing. prellisbio.com

PrellisBio is delighted to announce a human antibody discovery collaboration with Sanofi using our #EXIS platform. businesswire.com/news/home/2022…

Sanofi CEO Paul Hudson continues hunt for new tech, spearing a deal with organoid startup - endpts.com/sanofi-ceo-pau…

A deep dive with our founder Melanie Matheu, PhD where she discusses her background, inspiration, and what it takes to be a company founder.

In recognition of #WomensHistoryMonth, we’re celebrating the powerful contributions of #WomenInSTEM, including the achievements of the women at Prellis. Learn about our team's expertise in #AntibodyDiscovery and #TissueEngineering at prellisbio.com.

Prellis is bringing the human immune system into the lab with our Externalized Immune System (EXIS™) platform. Learn more at prellisbio.com/antibodydiscov….

Unprecedented access to the human immune system with the Externalized Immune System (EXIS) platform. Meet with the Prellis Bio team at BIO Convention via the BIO partnering system. #BIO2022 bit.ly/3Nzw2Py

Prellis is pioneering the new path to fully human antibody discovery, immunogenicity, and vaccine screening. Connect with our leadership team at #BIO2022. bit.ly/3Nzw2Py

We're thrilled to announce the launch of our new website, unveiling our groundbreaking EXIS™ platform for antibody discovery! Head over to our new website at prellisbio.com to explore the science behind our cutting-edge platform! #Biotechnology #AntibodyDiscovery #AI